faculty photo

Mark H. Schutta

G. Clayton Kyle Associate Professor in Diabetes
Department: Medicine

Contact information
Penn Rodebaugh Diabetes Center
4th Floor, Penn Tower
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-662-2468
Fax: 215-349-8529
Education:
B.A. (Political Science)
University of Wisconsin-Madison, Madison, WI, 1984.
M.D.
Thomas Jefferson University Medical College, Philadelphia, PA, 1993.
Post-Graduate Training
Intern, Internal Medicine, Thomas Jefferson University Hospital, 1993-1994.
Resident, Internal Medicine, Thomas Jefferson University Hospital, 1994-1997.
Fellow, Endocrinology, Diabetes and Metabolism, Hospital of the University of Pennsylvania, 1997-1999.
Permanent link
 

Description of Research Expertise

Dr. Schutta is involved in several research areas including the effects of bariatric surgery on diabetes remission and the association between coronary calcification and cardiovascular risk in type 2 diabetic patients.

Description of Clinical Expertise

Dr. Schutta specializes in the diagnosis and treatment of diabetes and hypoglycemia disorders. Dr. Schutta predominantly cares for patients with pre-diabetes, type 1 and type 2 diabetes as well as post-transplantation diabetes. He has a particular interest in diabetes prevention and in-patient management of diabetes and hyperglycemia. Dr. Schutta presently serves as Medical Director of the Penn Rodebaugh Diabetes Center.

Selected Publications

Martin SS., Qasim AN., Mehta NN., Wolfe M., Terembula K., Schwartz S., Iqbal N., Schutta M., Bagheri R., Reilly MP.: Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. Diabetes 58: 1887-1892, Dec 2009.

Schutta MH.: Diabetes and Hypertension. Journal of Cardiometabolic Syndrome Page: 124-130, Spring 2007.

Rickels MR., Schutta MH., Mueller R., Kapoor S., Markmann JF., Naji A., Teff KL.: Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients. J Clin Endocrinol Metab Dec 27 2006

Cardillo S., Schutta MH.: Repaglinide Induced Hypoglycemia in a Patient with Cystic Fibrosis-Related Diabetes Mellitus. Endo Trends 13(4): 6-7, 2006.

Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A., Teff KL.: Beta-cell function following human islet transplantation for type 1 diabetes. Diabetes 54(1): 100-6, Jan 2005.

Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A., Teff KL.: Beta-Cell Function Following Human Islet Transplantation for Type 1 Diabetes Mellitus: Preliminary Results. Oral presentation at the American Diabetes Association Meeting June 2007.

Reilly MP., Iqbal N., Schutta M., Wolfe ML., Scally M., Localio AR., Rader DJ., Kimmel SE.: Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 89(8): 3872-8, Aug 2004.

back to top
Last updated: 10/03/2014
The Trustees of the University of Pennsylvania